PRINCETON, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug ...

OpenAI has told Delhi HC that the Indian courts do not have the jurisdiction to hear a copyright infringement case against ...

For full year 2024, the Company expects total net revenues, adjusted non-GAAP EBITDA, and adjusted non-GAAP diluted EPS to be at or above the ...

The singer-songwriter made a name for herself in the 1990s by doing things her own way. She explains what she's letting go of ...

In a report released today, Gary Nachman from Raymond James reiterated a Buy rating on ANI Pharmaceuticals (ANIP – Research Report), with a ...